The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy.
Masahiro AdachiNaoki AoyamaMotohiro KojimaNaoya SakamotoSaori MiyazakiTetsuro TakiReiko WatanabeKazuto MatsuuraDaisuke KotaniTakashi KojimaTakeo FujitaKeiji TabuchiGenichiro IshiiShingo SakashitaPublished in: Journal of cancer research and clinical oncology (2022)
The area of residual tumor is a promising histopathological prognostic factor for patients with esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Moreover, it is a possible candidate histopathological factor for postoperative chemotherapy selection.